Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies

NCT00890955 is registered in ClinicalTrials.gov with Lawrence Einhorn as lead sponsor.

NCT NCT00890955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies
Lead sponsor
Lawrence Einhorn
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2009
Completion date
July 31, 2010
Enrollment
36 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer